Company intelligence / Profile preview
Oxford Vacmedix
Oxford, England, United Kingdomoxfordvacmedix.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Oxford Vacmedix has developed a proprietary ROP immunotherapy platform with two lead vaccine candidates—OVM–100 for cervical cancer and OVM–200 for survivin-expressing solid tumors. Both are being advanced toward clinical trials as monotherapies and in combination with immune-oncology agents. The company also has a diagnostic program for anti-microbial resistance. As of the latest information, no active clinical trials are registered on ClinicalTrials.gov.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Therapeutic cancer vaccines (immunotherapy)Diagnostics (for cancer and infectious diseases)Recombinant Overlapping Peptides (ROP) platform
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Changzhou Bioscience Group/CBIG in China for diagnostics development using ROP technologyseeking pharma partners for co-development and NHS hospitals for clinical trial participationInnovate UK partnership grant awarded.
Beyond the preview
Go deeper on Oxford Vacmedix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxford Vacmedix.